DrugDashboards

Market view

ganciclovir · Injection, Powder, Lyophilized, For Solution

1 marketed package NDCs · 1 active manufacturer

Most dispensed: 1.5 mg/g · Gel · #1 tube, with applicator/carton / 5 g in 1 tube, with applicator

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for ganciclovir, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • ZirganAug 19, 2026
    Price down
    NADAC $91.28475 → $91.25695 per unit (-0.03%)
  • ZirganJul 22, 2026
    Price down
    NADAC $91.31922 → $91.28475 per unit (-0.04%)

Same drug class

Other molecules FDA puts in Nucleoside Analog Antiviral, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Ganciclovir in shortage right now?
No. FDA does not currently list Ganciclovir in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Ganciclovir?
4 companies have marketed Ganciclovir in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Ganciclovir cost?
The typical pharmacy pays about $91.26 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.